Han Zhang-Han

Burning Rock Biotech

Guangzhou

China

SCHOLARLY PAPERS

2

DOWNLOADS

32

CITATIONS

1

Scholarly Papers (2)

The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

Number of pages: 37 Posted: 28 Jan 2019
Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, ACEA Therapeutics Inc., ACEA Therapeutics Inc., ACEA Therapeutics Inc., Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology and Guangdong Academy of Medical Sciences
Downloads 14 (575,755)

Abstract:

Loading...

Abivertinib, resistance, EGFR amplification

The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

Number of pages: 38 Posted: 01 Mar 2019
Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, Guangdong Academy of Medical Sciences, ACEA Therapeutics Inc., ACEA Therapeutics Inc., ACEA Therapeutics Inc., Guangdong Academy of Medical Sciences, Guangdong General Hospital, Guangdong Lung Cancer Institute, Department of Pulmonary Oncology and Guangdong Academy of Medical Sciences
Downloads 6 (630,954)

Abstract:

Loading...

EGFR; T790M; abivertinib; resistance; NSCLC

2.

TP53 Exon 8 Mutations are Associated with Shorter Survival in Advanced Lung Cancer Patients

Number of pages: 34 Posted: 08 Sep 2018
Chinese Academy of Medical Sciences, Cancer Hospital, Department of Medical Oncology, Central South University, Third Military Medical University, Chongqing Medical University, Yangzhou University - Department of Medical Oncology, Nanjing University, Southeast University (China), Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Burning Rock Biotech, Nanjing Medical University - Department of Medical Oncology and Government of the People's Republic of China - Department of Respiratory Medicine
Downloads 12 (572,293)

Abstract:

Loading...

TP53, TP53 Hot Exon Mutation, Lung Cancer, Biomarker